- Home
- ZCMD vs EDVA Comparison
ZCMD vs EDVA Comparison
Compare ZCMD & EDVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZCMD | EDVA |
|---|---|---|
| Founded | 2012 | N/A |
| Country | China | |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Beverages (Production/Distribution) |
| Sector | Real Estate | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0M | 1.9M |
| IPO Year | 2019 | 2012 |
Fundamental Metrics
Financial Performance| Metric | ZCMD | EDVA |
|---|---|---|
| Price | $1.00 | $0.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 306.5K |
| Earning Date | 04-28-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.30 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $73,066.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.02 | $0.23 |
| 52 Week High | $11.96 | $0.32 |
Technical Indicators
Market Signals| Indicator | ZCMD | EDVA |
|---|---|---|
| Relative Strength Index (RSI) | 50.37 | N/A |
| Support Level | $0.72 | N/A |
| Resistance Level | $0.97 | N/A |
| Average True Range (ATR) | 0.06 | 0.00 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 59.72 | 0.00 |
Price Performance
Historical ComparisonAbout ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provides healthcare information, education, and training services to healthcare professionals under its MDMOOC brand. It also provides focused patient management services through the Zhongxun IT system and WeChat mini program, and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.
About EDVA Endovia Health Sciences Inc. Common Stock
Endovia Health Sciences Inc is building a diversified cannabinoid health sciences platform through pharmaceutical innovation, strategic partnerships and disciplined execution. Endovia acquires, develops and commercializes differentiated cannabinoid health technologies across pharmaceutical, veterinary and consumer wellness markets. Endovia's product begins with CannEpil, a cannabinoid pharmaceutical asset, and extends into veterinary development and consumer wellness as the pipeline expands.